Search research articles
Contact Us
Filters
Showing results (371-380 of 425) with videos related to
Page
of 43
Sort By:
Vaccine
|
August 3, 2016
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women
Christine E Jones, Flor M Munoz, Hans M L Spiegel, et al.
The Lancet. Child & Adolescent Health
|
November 29, 2021
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
Louise F Hill, Michelle N Clements, Mark A Turner, et al.
Clinical and Translational Science
|
October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial
Susanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2017
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
Lola Madrid, Anna C Seale, Maya Kohli-Lynch, et al.
The Pediatric Infectious Disease Journal
|
February 14, 2025
Fostering Collaboration Across Nations: Report of the 6th International Neonatal and Maternal Immunization Symposium (INMIS), Costa Rica, 2024
Flor M Muñoz, Maria Luisa Avila Aguero, Clare L Cutland, et al.
The Lancet. Infectious Diseases
|
January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial
Mildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2017
Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses
Jennifer Hall, Nadine Hack Adams, Linda Bartlett, et al.
European Journal of Pediatrics
|
February 14, 2014
Current management of late onset neonatal bacterial sepsis in five European countries
Irja Lutsar, Corine Chazallon, Francesca Ippolita Calò Carducci, et al.
Pediatric Blood & Cancer
|
March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
Mariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
The Lancet. Global Health
|
December 20, 2024
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda
Eve Nakabembe, Melanie Greenland, Kyle Amaral, et al.
Page
of 43
Search research articles
Search
Showing results (371-380 of 425) with videos related to
Sort By:
Page
of 43
Vaccine
|
August 3, 2016
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women
Christine E Jones, Flor M Munoz, Hans M L Spiegel, et al.
The Lancet. Child & Adolescent Health
|
November 29, 2021
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
Louise F Hill, Michelle N Clements, Mark A Turner, et al.
Clinical and Translational Science
|
October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial
Susanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2017
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
Lola Madrid, Anna C Seale, Maya Kohli-Lynch, et al.
The Pediatric Infectious Disease Journal
|
February 14, 2025
Fostering Collaboration Across Nations: Report of the 6th International Neonatal and Maternal Immunization Symposium (INMIS), Costa Rica, 2024
Flor M Muñoz, Maria Luisa Avila Aguero, Clare L Cutland, et al.
The Lancet. Infectious Diseases
|
January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial
Mildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2017
Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses
Jennifer Hall, Nadine Hack Adams, Linda Bartlett, et al.
European Journal of Pediatrics
|
February 14, 2014
Current management of late onset neonatal bacterial sepsis in five European countries
Irja Lutsar, Corine Chazallon, Francesca Ippolita Calò Carducci, et al.
Pediatric Blood & Cancer
|
March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
Mariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
The Lancet. Global Health
|
December 20, 2024
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda
Eve Nakabembe, Melanie Greenland, Kyle Amaral, et al.
Page
of 43